Jaguar Gene Therapy

Jaguar Gene Therapy is a clinical-stage biotechnology company dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. They are committed to providing safe and effective treatments for a range of diseases, including galactosemia, genetic causes of autism spectrum disorder, and Type 1 diabetes. Jaguar leverages a proven management team, access to capital, and world-class clinical and AAV GMP manufacturing expertise to expedite development timelines and bring life-changing therapies to patients.

Jaguar has a diversified pipeline of gene therapy treatments, technologies, and approaches. Their initial programs utilize the proven and well-characterized AAV9 vector to target diseases with significant unmet need in sizeable patient populations. Jaguar has established strategic partnerships with key academic institutions, renowned experts, world-class laboratories, and essential suppliers. These partnerships provide access to potential future gene therapy pipeline opportunities and foster a collaborative environment dedicated to research and development.

Jaguar Gene Therapy is a biotechnology company dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases, with a particular focus on diseases that affect sizable patient populations. Their mission is driven by a belief in a world where patients and families no longer face the disheartening reality of limited treatment options. They strive to develop safe and effective therapies that address the root causes of these diseases, improving the lives of those affected and fostering a future where gene therapy can meaningfully change the trajectory of lives.

Jaguar Gene Therapy cultivates a culture of urgency and passion, driven by a deep commitment to improving the lives of patients and families impacted by severe genetic diseases. They value integrity, agility, and collaboration, fostering an environment where team members work together to swiftly and effectively bring breakthrough gene therapies to patients. The company encourages an open and transparent dialogue with patients and families, actively involving them in the drug development process and recognizing their unique perspectives.

Jaguar Gene Therapy prioritizes its people and values diversity, equity, and inclusion as a means to achieve its mission of accelerating breakthroughs in gene therapy. They foster a collaborative environment where individuals with varied backgrounds and perspectives work together to find solutions, supporting and respecting each other's contributions. This culture is built on their core values of Integrity, Agility, and Collaboration, which guide their interactions with patients, families, and the broader community.